The biotech says sales of its first commercial therapy, Ryoncil, were $20 million in the quarter ending June 30.

The U.S. FDA inspected Lupin's Pithampur Unit-2 manufacturing facility from July 08 to July 17, 2025. The inspection closed with the issuance of a Form-483 with four observations.

Samsung Galaxy M36 5G review: A quality experience above everything else ...

‘We have to see how bad the cut is’: India pacer injured ahead of Manchester Test, may need stitches Inside the World’s Largest Building: They Built an Entire City Indoors I’m 62 and superfit – these ...